Skip to content

Researcher Stories

Get to know the PhRMA Foundation’s award recipients.

Missing ALT Text

Combining Immunotherapy and Chemotherapy for Better Cancer Treatment

Kaitlyn Pierpont, a PhD student at Weill Cornell Medicine, is researching how to improve cancer treatment by combining two therapies: chemotherapy and chimeric antigen receptor (CAR) T-cell therapy.

Watch Now
Missing ALT Text

Looking Beyond GLP-1 Therapies to Treat Obesity

Kate Bowman, a PhD student at the University of Michigan, is investigating alternative therapeutic targets for treating obesity.

Read More
Missing ALT Text

How Checking the Wrong Box Led to the Right Career Path in Cancer Research

Ahmad Salman Sirajee, a PhD student at Rutgers University, is developing a noninvasive diagnostic tool that identifies patterns of DNA fragments in the bloodstream to help doctors better classify and monitor bladder cancer patients.

Watch Now

Problem-Solving to Fix Lab Equipment and Advance Cancer Therapy

Abe Wu, a PhD student at the University of Washington, is developing biomaterials to improve cancer cell therapies, which use engineered immune cells to target and kill tumors.

Awardee Spotlight

Ruida Hou, MD, PhD

  • St. Jude Children’s Research Hospital

“This fellowship is a tremendous milestone in my scientific journey. It will allow me to deepen our mechanistic understanding of pyrimidine metabolism vulnerabilities in ALL and accelerate efforts to translate these insights into precision therapies for children with cancer.”

Designing Tiny ‘Grenades’ to Penetrate Solid Cancer Tumors

Indrani Das, an MD‑PhD student at Case Western Reserve University, is developing a peptide that can penetrate solid cancer tumors to improve chimeric antigen receptor (CAR) T-cell therapy.

PhRMA Foundation
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.